{"id":"https://openalex.org/W4361890977","doi":"https://doi.org/10.1158/1078-0432.22484210","title":"Supplementary Table 3 from Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in 11C-Choline-PET/CT\u2013Identified Oligometastatic Castration-Resistant Prostate Cancer","display_name":"Supplementary Table 3 from Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in 11C-Choline-PET/CT\u2013Identified Oligometastatic Castration-Resistant Prostate Cancer","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361890977","doi":"https://doi.org/10.1158/1078-0432.22484210"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22484210","doi":"https://doi.org/10.1158/1078-0432.22484210","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22484210","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.22484210","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049144598","display_name":"Henan Zhang","orcid":"https://orcid.org/0000-0002-5680-4687","observed_orcids":["https://orcid.org/0000-0002-5680-4687"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Henan Zhang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5680-4687","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005887623","display_name":"Jacob J. Orme","orcid":"https://orcid.org/0000-0002-0319-0239","observed_orcids":["https://orcid.org/0000-0002-0319-0239"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jacob J. Orme","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0319-0239","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044836710","display_name":"Feven Abraha","orcid":"https://orcid.org/0000-0002-4168-4264","observed_orcids":["https://orcid.org/0000-0002-4168-4264"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Feven Abraha","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4168-4264","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052029955","display_name":"B.J. Stish","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B.J. Stish","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001313680","display_name":"Val J. Lowe","orcid":"https://orcid.org/0000-0002-5612-1667","observed_orcids":["https://orcid.org/0000-0002-5612-1667"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Val J. Lowe","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088539200","display_name":"Fabrice Lucien","orcid":"https://orcid.org/0000-0001-6149-345X","observed_orcids":["https://orcid.org/0000-0001-6149-345X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fabrice Lucien","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052777541","display_name":"Erik J. Tryggestad","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Erik J. Tryggestad","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006620678","display_name":"Michael S. Bold","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael S. Bold","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082402405","display_name":"Lance C. Pagliaro","orcid":"https://orcid.org/0000-0002-4209-3394","observed_orcids":["https://orcid.org/0000-0002-4209-3394"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lance C. Pagliaro","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108692006","display_name":"C. Richard Choo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Richard Choo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048817295","display_name":"Debra H. Brinkmann","orcid":"https://orcid.org/0000-0002-0812-3094","observed_orcids":["https://orcid.org/0000-0002-0812-3094"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Debra H. Brinkmann","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0812-3094","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012788874","display_name":"Matthew J. Iott","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthew J. Iott","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040586351","display_name":"Brian J. Davis","orcid":"https://orcid.org/0000-0002-8288-1096","observed_orcids":["https://orcid.org/0000-0002-8288-1096"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brian J. Davis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012709955","display_name":"Jorge Fernando Quevedo","orcid":"https://orcid.org/0000-0002-1572-3602","observed_orcids":["https://orcid.org/0000-0002-1572-3602"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Fernando Quevedo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044847415","display_name":"William Scott Harmsen","orcid":"https://orcid.org/0000-0001-7134-5362","observed_orcids":["https://orcid.org/0000-0001-7134-5362"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William S. Harmsen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073960684","display_name":"Brian Addis Costello","orcid":"https://orcid.org/0000-0003-1753-5928","observed_orcids":["https://orcid.org/0000-0003-1753-5928"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brian A. Costello","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1753-5928","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081519550","display_name":"Geoffrey Bates Johnson","orcid":"https://orcid.org/0000-0002-9781-4072","observed_orcids":["https://orcid.org/0000-0002-9781-4072"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Geoffrey B. Johnson","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9781-4072","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109270071","display_name":"Mark A. Nathan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark A. Nathan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109287755","display_name":"Kenneth R. Olivier","orcid":"https://orcid.org/0000-0002-3558-2341","observed_orcids":["https://orcid.org/0000-0002-3558-2341"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kenneth R. Olivier","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019525982","display_name":"Thomas Michael Pisansky","orcid":"https://orcid.org/0009-0009-4875-2061","observed_orcids":["https://orcid.org/0009-0009-4875-2061"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas M. Pisansky","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112904768","display_name":"Eugene D. Kwon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eugene D. Kwon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038413156","display_name":"Haidong Dong","orcid":"https://orcid.org/0000-0002-5782-2983","observed_orcids":["https://orcid.org/0000-0002-5782-2983"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Haidong Dong","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5782-2983","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5005150037","display_name":"Sean S. Park","orcid":"https://orcid.org/0000-0003-3814-853X","observed_orcids":["https://orcid.org/0000-0003-3814-853X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sean S. Park","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3814-853X","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.8256999850273132,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.8256999850273132,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.11249999701976776,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.01119999960064888,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/stereotactic-body-radiation-therapy","display_name":"stereotactic body radiotherapy","score":0.925000011920929},{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.8619999885559082},{"id":"https://openalex.org/keywords/oligometastatic-disease","display_name":"oligometastatic disease","score":0.9490000009536743},{"id":"https://openalex.org/keywords/11c-choline-pet-ct","display_name":"11C-choline PET/CT","score":0.9330000281333923},{"id":"https://openalex.org/keywords/immune-response","display_name":"immune response","score":0.3889999985694885},{"id":"https://openalex.org/keywords/event-free-survival","display_name":"event-free survival","score":0.9710000157356262},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7789999842643738}],"concepts":[{"id":"https://openalex.org/C187625094","wikidata":"https://www.wikidata.org/wiki/Q7388452","display_name":"SABR volatility model","level":4,"score":0.8279051780700684},{"id":"https://openalex.org/C19617505","wikidata":"https://www.wikidata.org/wiki/Q156986","display_name":"Ablative case","level":3,"score":0.8097331523895264},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7754113674163818},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.6866623163223267},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4530501067638397},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4473968744277954},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.4360511302947998},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.4333471953868866},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.42036348581314087},{"id":"https://openalex.org/C2780387249","wikidata":"https://www.wikidata.org/wiki/Q973234","display_name":"Radiosurgery","level":3,"score":0.412361204624176},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.3815600275993347},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.24370679259300232},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.23821723461151123},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C106159729","wikidata":"https://www.wikidata.org/wiki/Q2294553","display_name":"Financial economics","level":1,"score":0.0},{"id":"https://openalex.org/C85393063","wikidata":"https://www.wikidata.org/wiki/Q596307","display_name":"Stochastic volatility","level":3,"score":0.0},{"id":"https://openalex.org/C91602232","wikidata":"https://www.wikidata.org/wiki/Q756115","display_name":"Volatility (finance)","level":2,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.22484210","doi":"https://doi.org/10.1158/1078-0432.22484210","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22484210","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.22484210.v1","doi":"https://doi.org/10.1158/1078-0432.22484210.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22484210.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22484210","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Table_3_from_Phase_II_Evaluation_of_Stereotactic_Ablative_Radiotherapy_SABR_and_Immunity_in_sup_11_sup_C-Choline-PET_CT_Identified_Oligometastatic_Castration-Resistant_Prostate_Cancer/22484210","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22484210","doi":"https://doi.org/10.1158/1078-0432.22484210","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22484210","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3204613195","https://openalex.org/W4361958867","https://openalex.org/W3094523290","https://openalex.org/W3124853404","https://openalex.org/W2921789984","https://openalex.org/W4399829865","https://openalex.org/W4223943711","https://openalex.org/W4387206520","https://openalex.org/W3094498203","https://openalex.org/W4307147514"],"abstract_inverted_index":{"Supplementary":[0],"Table":[1],"3.":[2],"Baseline":[3],"TTR":[4,33,39],"and":[5,20,26],"changes":[6],"after":[7],"SBRT":[8],"predict":[9],"outcomes":[10],"in":[11,38],"oligometastatic":[12],"CRPC.":[13],"Median":[14],"event-free":[15],"survival":[16,17],"(in":[18],"months)":[19],"hazard":[21],"ratio":[22],"for":[23],"each":[24],"outcome":[25],"group":[27],"is":[28],"given,":[29],"stratified":[30],"by":[31],"baseline":[32,42],"levels":[34,40],"(left)":[35],"or":[36],"change":[37],"from":[41],"to":[43],"day":[44],"14":[45],"post-SBRT.":[46],"ns":[47],"not":[48,51],"significant;":[49],"N/A":[50],"applicable":[52]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}
